Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: IRADIMED CORPORATION

Market Cap 1.17B 1.03B 949M 888M 1.66B 111B 1.69B 11.39B 4.41B 54.48B 4.4B 4.31B 189B P/E 2026 *
48x
P/E 2027 * 42.4x
Enterprise Value 1.17B 1.03B 949M 888M 1.66B 111B 1.69B 11.39B 4.41B 54.48B 4.4B 4.31B 189B EV / Sales 2026 *
12.9x
EV / Sales 2027 * 11.6x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week+0.77%
Current month+2.08%
1 month-0.42%
3 months-6.70%
6 months-4.19%
Current year-4.86%
1 week 89.69
Extreme 89.69
93.69
1 month 87.91
Extreme 87.91
98.41
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Director/Board Member 73 01/01/2014
Director/Board Member 61 02/09/2025
Director/Board Member 70 01/01/2019
Date Insider Type Main position Quantity % Market Cap.
06-04Sell

Director

-3,000 0.0235%
06-01Sell

Chief Executive Officer

-2,500 0.0196%
05-27Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+0.77%+55.56%+95.34% 1.17B
-1.60%-9.48%-20.19%-23.36% 12.61B
+0.56%-3.98%+78.82%+15.51% 4.84B
+0.16%-4.11%-36.73%-65.06% 1.2B
-0.18%-5.22%-33.90%-43.72% 1.17B
+0.60%-2.20%-37.24% - 950M
+1.90%-5.87%+201.78%+191.23% 664M
+2.24%-0.08% - - 324M
-0.31%-1.74%-58.61%+191.83% 241M
-1.01%+6.88%+112.63%-33.56% 148M
Average +0.30%-3.28%+29.12%+41.02% 2.33B
Weighted average by Cap. -0.62%-5.79%+9.10%-3.12%

Financials

2026 *2027 *
Net sales 91.2M 80.12M 73.83M 69.11M 129M 8.64B 132M 886M 343M 4.24B 342M 335M 14.73B 101M 88.64M 81.68M 76.46M 143M 9.56B 146M 981M 380M 4.69B 379M 371M 16.3B
Net income 24.55M 21.57M 19.87M 18.6M 34.86M 2.33B 35.44M 239M 92.37M 1.14B 92.16M 90.18M 3.97B 27.8M 24.42M 22.5M 21.07M 39.47M 2.63B 40.13M 270M 105M 1.29B 104M 102M 4.49B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
23/06/26 $92.55 +0.94% 95,489
22/06/26 $91.69 -0.55% 95,062
18/06/26 $92.20 +1.22% 182,287
17/06/26 $91.09 -0.82% 121,914
16/06/26 $91.84 +1.16% 132,802
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
91.69USD
Average target price
118.00USD
Spread / Average Target
+28.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!